Compare JAZZ & OC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JAZZ | OC |
|---|---|---|
| Founded | 2003 | 1938 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4B | 8.7B |
| IPO Year | 2007 | 2006 |
| Metric | JAZZ | OC |
|---|---|---|
| Price | $181.95 | $107.33 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 12 |
| Target Price | ★ $216.92 | $153.00 |
| AVG Volume (30 Days) | 937.7K | ★ 1.6M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.16% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,618,693,000.00 | N/A |
| Revenue This Year | $6.17 | N/A |
| Revenue Next Year | $7.66 | $3.73 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $95.49 | $97.53 |
| 52 Week High | $198.00 | $159.42 |
| Indicator | JAZZ | OC |
|---|---|---|
| Relative Strength Index (RSI) | 54.12 | 40.80 |
| Support Level | $176.67 | $97.53 |
| Resistance Level | $182.99 | $118.16 |
| Average True Range (ATR) | 4.96 | 4.13 |
| MACD | -0.94 | -0.37 |
| Stochastic Oscillator | 39.13 | 40.95 |
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.